|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Cash segregated under regulatory requirements | ||||||||||||||||||||
| Financial instruments owned, at fair value | ||||||||||||||||||||
| Reverse repurchase agreements | ||||||||||||||||||||
| Receivables from broker-dealers, clearing organizations, customers and related broker-dealers | ||||||||||||||||||||
| Accrued commissions and other receivables, net | ||||||||||||||||||||
| Loan receivable from related parties | ||||||||||||||||||||
| Loans, forgivable loans and other receivables from employees and partners, net | ||||||||||||||||||||
| Fixed assets, net | ||||||||||||||||||||
| Investments | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Other intangible assets, net | ||||||||||||||||||||
| Receivables from related parties | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities and Equity | ||||||||||||||||||||
| Short-term borrowings | ||||||||||||||||||||
| Repurchase agreements | ||||||||||||||||||||
| Liabilities | ||||||||||||||||||||
| Short-term borrowings from related parties | ||||||||||||||||||||
| Accrued compensation | ||||||||||||||||||||
| Payables to broker-dealers, clearing organizations, customers and related broker-dealers | ||||||||||||||||||||
| Payables to related parties | ||||||||||||||||||||
| Accounts payable, accrued and other liabilities | ||||||||||||||||||||
| Notes payable and other borrowings | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Redeemable partnership interest | ||||||||||||||||||||
| Equity | ||||||||||||||||||||
| Stockholders’ equity: | ||||||||||||||||||||
| Common stock value | ||||||||||||||||||||
| Class A Common Stock | ||||||||||||||||||||
| Class B Common Stock | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Treasury stock, at cost: 43,459,123 and 13,479,847 shares of Class A common stock at September 30, 2024 and December 31, 2023, respectively | ||||||||||||||||||||
| Treasury stock, at cost: 91,922,990 and 81,745,750 shares of Class A common stock at June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Class A Common Stock | ||||||||||||||||||||
| Total treasury stock, at cost: 91,922,990 and 81,745,750 shares of Class A common stock at June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Retained deficit | ||||||||||||||||||||
| Accumulated other comprehensive income (loss) | ||||||||||||||||||||
| Total stockholders’ equity | ||||||||||||||||||||
| Noncontrolling interest in subsidiaries | ||||||||||||||||||||
| Total equity | ||||||||||||||||||||
| Total liabilities and equity | ||||||||||||||||||||
| Common stock, shares issued (in shares) | ||||||||||||||||||||
| Class A Common Stock | ||||||||||||||||||||
| Class B Common Stock | ||||||||||||||||||||
| Common stock, shares outstanding (in shares) | ||||||||||||||||||||
| Class A Common Stock | ||||||||||||||||||||
| Class B Common Stock | ||||||||||||||||||||
Loading...
